Venture Capital

The state of investment: 'biotech is up'

Dispatches from BIO 2016

The state of investment: 'biotech is up'

By Melissa Fassbender

The biopharmaceutical industry broke several records in 2015 – but to continue the trend will require a sustained investment from multiple stakeholders.

Architects' plans for the Nottingham, UK facility

$47m innovation facility built in Nottingham, UK

By Fiona BARRY

The UK’s BioCity in Nottingham is adding a £30m ($47m) facility to house life science start-ups including CROs. The site will also become a hunting ground for a soon-to-launch venture capital fund which will invest in the SME tenants.


Follow us


View more


Featured Suppliers

All suppliers